在竞争性风险下使用纵向修改治疗策略进行因果生存分析
Iván Díaz1, Katherine L Hoffman2, Nima S Hejazi3
1Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, NY, 10016, USA. ivan.diaz@nyu.edu.
Lifetime data analysis
|August 24, 2023
概括
这项研究引入了纵向研究中因果推断的新方法,将纵向修改治疗策略 (LMTP) 扩展到处理具有竞争风险的时间到事件结果. 该方法可以在复杂的健康场景中改善因果效应估计.
科学领域:
- 因果推理的原因推理.
- 生物统计学 生物统计学
- 流行病学 流行病学
背景情况:
- 纵向修改治疗策略 (LMTP) 提供了一种新的方法来定义和估计与治疗相关的因果参数.
- 随着时间的推移,LMTP对于分析具有多种治疗方法的纵向研究至关重要.
- 现有的方法可能无法充分解决因竞争事件而复杂的时间到事件结果.
研究的目的:
- 将LMTP方法扩展到与竞争事件的时间到事件结果.
- 开发非参数的,局部有效的估计器,用于这种环境中的因果关系.
- 应用扩展的LMTP来分析化时间对COVID-19患者急性损伤的影响.
主要方法:
- 扩展LMTP方法论用于竞争风险.
- 开发识别结果和非参数局部有效估计器.
- 使用灵活的,数据适应性回归技术来最大限度地减少模型错误规范偏差.
- 确保估计器保留了诸如[公式:参见文本]-consistency等重要的非对称性属性.
主要成果:
- 该研究为在具有竞争风险的纵向研究中识别和估计因果效应提供了一个框架.
- 采用数据适应性方法来提高估计器对模型错误规范的稳定性.
- 该方法通过对COVID-19患者数据的应用来证明.
结论:
- 扩展的LMTP方法有效地解决了复杂的因果推理问题,使用时间到事件数据和竞争风险.
- 建议的估计器在现实应用中提供了更高的准确性和稳定性.
- 这一进步对流行病学和临床研究产生了重大影响,特别是在重症监护机构.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
222
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
222
Assumptions of Survival Analysis
154
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
154
Introduction To Survival Analysis
277
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
277
Censoring Survival Data
129
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
129
Actuarial Approach
96
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
96
Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383


